Current Gastroenterology Reports

, Volume 5, Issue 2, pp 105–109

Genetic factors in pancreatitis

  • James H. Grendell


A number of genetic mutations have recently been identified that appear to be important in the development of pancreatitis. Point mutations in the cationic trypsinogen gene are capable of initiating pancreatitis. These mutations also provide important insights into the pathophysiology of acute pancreatitis and into potential connections between acute and chronic pancreatitis. Mutations in the genes encoding for the pancreatic secretory trypsin inhibitor and the cystic fibrosis transmembrane conductance regulator more likely work in concert with other genes and environmental factors in affecting disease susceptibility. Although the subject so far has recieved only a limited amount of study, genetic polymorphisms in a wide range of genes relating to pancreatic function and to regulation of inflammation are likely to play major roles in determining each individual’s susceptibility to developing pancreatitis, and its severity if it does develop.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References and Recommended Reading

  1. 1.
    Whitcomb DC, Gorry MC, Preston RA, et al.: Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene. Nat Genet 1996, 14:141–145.PubMedCrossRefGoogle Scholar
  2. 2.
    Whitcomb DC: Genetic predispositions to acute and chronic pancreatitis. Med Clin North Am 2000, 84:531–547.PubMedCrossRefGoogle Scholar
  3. 3.
    Gorry MC, Gabbaizedeh D, Furey W, et al.: Mutations in the cationic trypsinogen gene are associated with recurrent acute and chronic pancreatitis. Gastroenterology 1997, 113:1063–1068.PubMedCrossRefGoogle Scholar
  4. 4.
    Sahin-Toth M, Graf L, Toth M: Trypsinogen stabilization by mutation Arg117-> His: a unifying pathomechanism for hereditary pancreatitis? Biochem Biophys Res Commun 1999, 264:505–508.PubMedCrossRefGoogle Scholar
  5. 5.
    O’Reilly DA, Kingsnorth AN: Hereditary pancreatitis and mutations of the cationic trypsinogen gene. Br J Surg 2000, 87:708–717.PubMedCrossRefGoogle Scholar
  6. 6.
    Nishimori I, Kamakura M, Fujikawa-Adachi K, et al.: Mutations in exons 2 and 3 of the cationic trypsinogen gene in Japanese families with hereditary pancreatitis. Gut 1999, 44:259–263.PubMedCrossRefGoogle Scholar
  7. 7.
    Witt H, Luck W, Becker M: A signal peptide cleavage site mutation in the cationic trypsinogen gene is strongly associated with chronic pancreatitis. Gastroenterology 1999, 117:7–10.PubMedCrossRefGoogle Scholar
  8. 8.
    Ferec C, Raguenes O, Salomon R, et al.: Mutations in the cationic trypsinogen gene and evidence for genetic heterogeneity in hereditary pancreatitis. J Med Genet 1999, 36:228–232.PubMedGoogle Scholar
  9. 9.
    Teich N, Ockenga J, Hoffmeister A: Chronic pancreatitis associated with an activation peptide mutation that facilitates trypsin activation. Gastroenterology 2000, 119:461–465.PubMedCrossRefGoogle Scholar
  10. 10.
    Teich N, Bauer N, Mössner J, Keim V: Mutational screening of patients with nonalcoholic chronic pancreatitis: identification of further trypsinogen variants. Am J Gastroenterol 2002, 97:341–346. In this study, the N346 mutation in SPINK 1 is the most frequent genetic risk factor for idiopathic pancreatitis. Three novel mutations found in the cationic trypsinogen gene are of uncertain significance.PubMedGoogle Scholar
  11. 11.
    Amann ST, Gates LK Jr, Aston CE: Expression and penetrance of the hereditary pancreatitis phenotype in monozygotic twins. Gut 2001, 48:542–547.PubMedCrossRefGoogle Scholar
  12. 12.
    Chen JM, Piepoli Bis A, Le Bodic L, et al.: Mutational screening of the cationic trypsinogen gene in a large cohort of subjects with idiopathic chronic pancreatitis. Clin Genet 2001, 59:189–193.PubMedCrossRefGoogle Scholar
  13. 13.
    Hassan Z, Mohan V, McDermott MF, et al.: Pancreatitis in fibrocalculous pancreatic diabetes mellitus is not associated with common mutations in the trypsinogen gene. Diabetes Metab Rev 2000, 16:454–457.CrossRefGoogle Scholar
  14. 14.
    Truninger K, Kock J, Wirth HP, et al.: Trypsinogen gene mutations in patients with chronic or recurrent acute pancreatitis. Pancreas 2001, 22:18–23.PubMedCrossRefGoogle Scholar
  15. 15.
    Monaghan KG, Jackson CE, KuKuruga DL, Feldman GL: Mutation analysis of the cystic fibrosis and cationic trypsinogen genes in patients with alcohol-related pancreatitis. Am J Med Genet 2000, 94:120–124.PubMedCrossRefGoogle Scholar
  16. 16.
    Ockenga J, Stuhrmann M, Ballmann M, et al.: Mutations of the cystic fibrosis gene, but not cationic trypsinogen gene, are associated with recurrrent or chronic idiopathic pancreatitis. Am J Gastroenterol 2000, 95:2061–2067.PubMedCrossRefGoogle Scholar
  17. 17.
    Rossi L, Whitcomb DC, Ehrlich GD, et al.: Lack of R117H mutation in the cationic trypsinogen gene in patients with tropical pancreatitis from Bangladesh. Pancreas 1998, 17:278–280.PubMedCrossRefGoogle Scholar
  18. 18.
    Keim V: Genetic risk factors in pancreatic diseases: significance for general practice. Medizinische Klinik 2002, 97:278–284. The author recommends that patients with genetic mutations associated with pancreatitis should abstrain from use of alcohol and tobacco.PubMedCrossRefGoogle Scholar
  19. 19.
    Lowenfels AB, Maissonneuve P, DiMagno EP, et al.: Hereditary pancreatitis and the risk of pancreatic cancer: International Hereditary Pancreatitis Study Group. J Natl Cancer Inst 1997, 89:442–446.PubMedCrossRefGoogle Scholar
  20. 20.
    Cavallini G, Tittobello A, Frulloni L, et al.: Gabexate for the prevention of pancreatic damage related to endoscopic retrograde cholangiopancreatography. N Engl J Med 1996, 335:919–923.PubMedCrossRefGoogle Scholar
  21. 21.
    Ammann RW, Heitz PU, Klöppel G: Course of alcoholic chronic pancreatitis: a prospective clinicomorphological long-term study. Gastroenterology 1996, 111:224–231.PubMedCrossRefGoogle Scholar
  22. 22.
    Witt H, Luck W, Hennies HC, et al.: Mutations in the gene encoding the serine protease inhibitor, Kazal type 1 are associated with chronic pancreatitis. Nat Genet 2000, 25:213–216.PubMedCrossRefGoogle Scholar
  23. 23.
    Pfutzer RH, Barmada MM, Brunskill APJ, et al.: SPINK/PSTI polymorphisms act as disease modifiers in familial and chronic pancreatitis. Gastroenterology 2000, 119:615–623.PubMedCrossRefGoogle Scholar
  24. 24.
    Drenth JP, Te Morsche R, Jansen JB: Mutations in serine protease inhibitor Kazal type 1 are strongly associated with chronic pancreatitis. Gut 2002, 50:687–692. An N34S SPINK 1 mutation was found in 12% of patients with alcoholic or idiopathic acute pancreatitis.PubMedCrossRefGoogle Scholar
  25. 25.
    Kaneko K, Nagasaki Y, Furukawa T: Analysis of the human pancreatic secretory trypsin inhibitor gene mutations in Japanese patients with chronic pancreatitis. J Human Genet 2001, 46:293–297.CrossRefGoogle Scholar
  26. 26.
    Schneider A, Suman A, Rossi L, et al.: SPINK 1/PSTI mutations are associated with tropical pancreatitis and type II diabetes mellitus in Bangladesh. Gastroenterology 2002, 123:1026–1030. The N34S mutation in SPINK 1 is strongly associated with tropical calcific pancreatitis and fibrocalculous pancreatic diabetes.PubMedCrossRefGoogle Scholar
  27. 27.
    Hassan Z, Mohan V, Ali L, et al.: SPINK 1 is a susceptibility gene for fibrocalculous pancreatic diabetes in subjects from the Indian subcontinent. Am J Hum Genet 2002, 71:964–968. This report provides further evidence of a strong association between the N34S SPINK 1 mutation and tropical pancreatitis.PubMedCrossRefGoogle Scholar
  28. 28.
    Cohn JA, Friedman KJ, Noone PG, et al.: Relation between mutations of the cystic fibrosis gene and idiopathic pancreatitis. N Engl J Med 1998, 339:653–658.PubMedCrossRefGoogle Scholar
  29. 29.
    Sharer N, Schwarz M, Malone G, et al.: Mutations of the cystic fibrosis gene in patients with chronic pancreatitis. N Engl J Med 1998, 339:645–652.PubMedCrossRefGoogle Scholar
  30. 30.
    Noone PG, Zhou Z, Silverman LM, et al.: Cystic fibrosis gene mutations and pancreatitis risk: relation to epithelial ion transport and trypsin inhibitor gene mutations. Gastroenterology 2001, 121:1310–1319. The combination of two CFTR mutations and an N34S SPINK 1 mutation raises the risk of pancreatitis 900-fold.PubMedCrossRefGoogle Scholar
  31. 31.
    Powell JJ, Fearon KCH, Siriwardena AK, Ross JA: Evidence against a role for polymorphisms at tumor necrosis factor, interleukin-1 and interleukin-1 receptor antagonist gene loci in the regulation of disease severity in acute pancreatitis. Surgery 2001, 129:633–640. No differences in the frequencies of polymorphisms were found between patients with pancreatitis and healthy control subjects for genes involved in regulating the systemic inflammatory response.PubMedCrossRefGoogle Scholar
  32. 32.
    Buter A, Beksdale J, Gallagher G, et al.: Microsatellite polymorphism at the human TNF and IL-10 loci in acute pancreatitis [abstract]. Gastroenterology 2000, 118:A195.CrossRefGoogle Scholar
  33. 33.
    Galllagher GE, Chong P, Eksdale J, et al.: A candidate gene study in predicted severe acute pancreatitis [abstract]. Gastroenterology 2001, 120:A468.CrossRefGoogle Scholar
  34. 34.
    Teich N, Walther K, Bodeker H, et al.: Relevance of variants in serum antiproteinases for the course of chronic pancreatitis. Scand J Gastroenterol 2002, 37:360–365. This study suggests that variants in α-1-antitrypsin may have some moderating effect on the course of chronic nonalcoholic pancreatitis.PubMedCrossRefGoogle Scholar
  35. 35.
    Dusetti NMJ, Tomasini R, Azizi A, et al.: Expression profiling in pancreas during the acute phase of pancreatitis using cDNA microarrays. Biochem Biophys Res Commun 2000, 277:660–667.PubMedCrossRefGoogle Scholar

Copyright information

© Current Science Inc. 2003

Authors and Affiliations

  • James H. Grendell
    • 1
  1. 1.Division of Gastroenterology, Hepatology, and NutritionWinthrop University HospitalMineolaUSA

Personalised recommendations